Covered recipient · General Payments record
JAIMIE TE
General Payments · PY2024
$256.81
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.81 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $67.24 | 3 |
| VIVUS LLC | $62.03 | 3 |
| Sumitomo Pharma America, Inc. | $48.79 | 2 |
| Almatica Pharma Inc. | $31.07 | 1 |
| Acerta Pharma LLC | $24.57 | 1 |
| GlaxoSmithKline, LLC. | $23.11 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $256.81 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Almatica Pharma LLC | $31.07 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137619401 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.57 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104462316 | CMS |
| GlaxoSmithKline, LLC. | $23.11 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116195063 | CMS |
| Lilly USA, LLC | $22.71 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135671940 | CMS |
| Lilly USA, LLC | $21.55 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135686780 | CMS |
| Lilly USA, LLC | $22.98 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135686043 | CMS |
| Sumitomo Pharma America, Inc. | $29.75 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148999058 | CMS |
| Sumitomo Pharma America, Inc. | $19.04 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148999060 | CMS |
| VIVUS LLC | $21.18 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421337 | CMS |
| VIVUS LLC | $21.48 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421339 | CMS |
| VIVUS LLC | $19.37 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.